By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aileron Therapeutics 

281 Albany Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-995-0900 Fax: 617-995-2410


SEARCH JOBS



Segment
Pharmaceuticals





Company News
Aileron Therapeutics To Present At Cowen and Company 34th Annual Health Care Conference On March 4, 2014 3/3/2014 7:24:28 AM
Aileron Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/10/2014 10:10:09 AM
Aileron Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/10/2014 9:39:45 AM
Big Pharma Quartet Dumps $30 Million Behind Aileron Therapeutics' P53 Peptide Drug 11/18/2013 8:07:26 AM
Aileron Therapeutics Publishes Data Demonstrating ATSP-7041 as First-in-class p53 Pathway Re-activator for the Treatment of Solid and Hematologic Cancers 8/15/2013 10:45:31 AM
Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial 5/7/2013 11:01:34 AM
Aileron Therapeutics Presents New Preclinical Data on Stapled Peptide Inhibitor of Cancer Transcription Factor HIF-1a at American Association for Cancer Research Annual Meeting 4/10/2013 6:59:16 AM
Aileron Therapeutics Presents New Data on Stapled Peptide Oncology Program at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics 11/7/2012 9:20:19 AM
Aileron Therapeutics to Present at Upcoming Scientific Conferences and Industry Events 10/31/2012 7:39:13 AM
Aileron Therapeutics Unveils New Therapeutic Drug Program; Appoints Hubert C. Chen, M.D., to Vice President of Clinical Development 9/6/2012 10:18:00 AM
123
//-->